PT - JOURNAL ARTICLE AU - Jayedi, Ahmad AU - Khan, Tauseef Ahmad AU - Mirrafiei, Amin AU - Jabbarzadeh, Bahareh AU - Hosseini, Yasaman AU - Motlagh, Sheida AU - Jibril, Aliyu Tijani AU - Shahinfar, Hossein AU - Shab-Bidar, Sakineh TI - Dose-dependent effect of nuts on blood pressure: a systematic review and meta-analysis of randomized controlled trials AID - 10.1101/2021.05.21.21257564 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.21.21257564 4099 - http://medrxiv.org/content/early/2021/05/23/2021.05.21.21257564.short 4100 - http://medrxiv.org/content/early/2021/05/23/2021.05.21.21257564.full AB - Objective Traditional pairwise meta-analyses indicated that nuts consumption can improve blood pressure. We iamed to determine the dose-dependent effect of nuts on systolic (SBP) and diastolic blood pressure (DBP) in adults.Methods A systematic search was undertaken in PubMed, Scopus, and ISI Web of Science till March 2021. Randomized controlled trials (RCT) evaluating the effects of nuts on SBP and DBP in adults were included. We estimated change in blood pressure for each 20 g/d increment in nut consumption in each trial and then, calculated mean difference (MD) and 95%CI using a random-effects model. We estimated dose-dependent effect using a dose-response meta-analysis of differences in means. The certainty of evidence was rated using the GRADE instrument, with the minimal clinically important difference being considered 2 mmHg.Results A total of 31 RCTs with 2784 participants were included. Each 20 g/d increase in nut consumption reduced SBP (MD: -0.50 mmHg, 95%CI: -0.79, -0.21; I2 = 12%, n = 31; GRADE = moderate certainty) and DBP (MD: -0.23 mmHg, 95%CI: -0.38, -0.08; I2 = 0%, n = 31; GRADE = moderate certainty). The effect of nuts on SBP was more evident in patients with type 2 diabetes (MD: -1.31, 95%CI: -2.55, -0.05; I2 = 31%, n = 6). The results were robust in the subgroup of trials with low risk of bias. Levels of SBP decreased proportionally with the increase in nuts consumption up to 40 g/d (MD40g/d: -1.60, 95%CI: -2.63, -0.58), and then appeared to plateau with a slight upward curve. A linear dose-dependent reduction was seen for DBP, with the greatest reduction at 80 g/d (MD80g/d: -0.80, 95%CI: -1.55, -0.04).Conclusions The available evidence provides a good indication that nut consumption can result in a small improvement in blood pressure in adults. Well-designed trials are needed to confirm the findings in long term follow-up.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is a systematic review studyClinical Protocols https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=247346 Funding StatementThis research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in the present study will be provided upon request.